Canadian AI in Life Sciences Delegation

About

The Canadian AI in Life Sciences Innovation R&D Partnering Delegation to South Korea, organized by Global Affairs Canada and the National Research Council IRAP, invites innovative Canadian SMEs to connect with potential partners in the South Korean market, focusing on AI applications in drug discovery, clinical trial management, and personalized medicine, with financial support available for eligible participants.

Benefits

• Connect with major pharmaceutical companies and healthcare organizations in South Korea
• Maximize visibility and partnership opportunities within a curated innovation ecosystem
• Potential financial support covering up to 50% of eligible expenses including airfare, accommodation, and registration fees

Eligibility Criteria

• Canadian small-to-medium-sized enterprises (SMEs) applying AI technologies to life sciences
• Profit-oriented
• Incorporated in Canada
• Previous experience in commercializing technology
• Capacity and interest to co-develop technology with Korean partners
• Commitment to expanding activities to the Korean market
• Sufficient working capital and human resources for multi-year R&D collaboration